Edition:
United States

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

3.04USD
23 Apr 2018
Change (% chg)

$-0.08 (-2.56%)
Prev Close
$3.12
Open
$3.13
Day's High
$3.13
Day's Low
$2.96
Volume
45,139
Avg. Vol
63,634
52-wk High
$8.66
52-wk Low
$2.96

Chart for

About

Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a... (more)

Overall

Beta: -0.47
Market Cap(Mil.): $97.45
Shares Outstanding(Mil.): 31.23
Dividend: --
Yield (%): --

Financials

  VIVE.OQ Industry Sector
P/E (TTM): -- 33.33 33.60
EPS (TTM): -2.13 -- --
ROI: -216.86 9.89 13.19
ROE: -- 14.70 15.00

BRIEF-Viveve Announces Pricing Of Public Offering Of Shares

* VIVEVE ANNOUNCES PRICING OF PUBLIC OFFERING OF SHARES OF COMMON STOCK

Feb 08 2018

BRIEF-Viveve Announces Proposed Public Offering Of Shares Of Common Stock

* VIVEVE ANNOUNCES PROPOSED PUBLIC OFFERING OF SHARES OF COMMON STOCK

Feb 07 2018

BRIEF-Viveve Announces Preliminary 2017 Fourth Quarter Results

* VIVEVE ANNOUNCES PRELIMINARY 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS AND PROVIDES 2018 REVENUE GUIDANCE

Jan 04 2018

BRIEF-Viveve Medical Inc files for mixed shelf of up to $50 million

* Viveve Medical Inc files for mixed shelf of up to $50 million Source text: (http://bit.ly/2zIf6EQ) Further company coverage:

Nov 08 2017

BRIEF-Viveve reports Q3 loss per share $0.50

* Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

Nov 08 2017

Earnings vs. Estimates